HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced cervical cancer-Reference-Cited by-同舟云学术

HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced cervical cancer

Published:2021-06 Issue:3 Volume:6 Page:100154
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Cabel L.,Bonneau C.,Bernard-Tessier A.,Héquet D.,Tran-Perennou C.,Bataillon G.,Rouzier R.,Féron J.-G.,Fourchotte V.,Le Brun J.-F.,Benoît C.,Rodrigues M.,Scher N.,Minsat M.,Legrier M.-E.,Bièche I.,Proudhon C.,Sastre-Garau X.,Bidard F.-C.,Jeannot E.

Funder

Ligue Nationale Contre Le Cancer

INCa

Fondation ARC pour la Recherche sur Le Cancer

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference39 articles.

1. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Marth;Ann Oncol,2017

2. Disease courses in patients with residual tumor following concurrent chemoradiotherapy for locally advanced cervical cancer;Kim;Gynecol Oncol,2017

3. Posttreatment cut-off levels of squamous cell carcinoma antigen as a prognostic factor in patients with locally advanced cervical cancer treated with radiotherapy;Kawaguchi;J Gynecol Oncol,2013